قارن بين أفضل أطباء سرطان الجلد والأسعار في إسبانيا. اعثر على أفضل تطابق لك هنا.
سنختار لك أفضل الأطباء حسب احتياجاتك وميزانيتك.
تمت مراجعة المقالة طبيا من قبل فهد مولود
محرر طبي وعالم بياناتأفضل الأطباء
2
إسبانيا
التقييمات
14000+
من مرضى حقيقيين
احصل على خطط علاجية مخصصة مجانية واختر أفضل خيار. بدون التزام · بدون دفعات لخدماتنا
أجرى أكثر من 2000 جراحة موس - يعد الدكتور غارسيس غاتناو رائدًا في علاج سرطان الجلد في مركز تكنون الطبي.
يتخصص الدكتور خيسوس سوبرينو في العلاج المناعي للميلانوما، حيث ساهم في تجارب محورية أحدثت ثورة في علاج الميلانوما بأدوية مثل بيمبروليزوماب ونيفولوماب.
قد يكون اختيار العيادة في الخارج أمرًا مرهقًا. في Bookimed، حيث ساعدنا أكثر من 800 ألف مريض، نحن نتفهم مخاوفك. نعرف كيفية العثور على الأطباء الموثوقين، وأفضل خيارات الجودة والسعر، وحلول حتى للحالات المعقدة. نحن هنا لإرشادك في كل خطوة على الطريق.
Yan Matsiivskiy
رئيس فريق المنسق الطبي
تم توجيه أكثر من 4300+ رحلة مرضى
3 سنة في Bookimed
896 مريض من Spain وجدوا طبيبهم عبرنا هذا الشهر
اختبار لمدة دقيقتين
أخبرنا بهدفك، ميزانيتك، وخطتك الزمنية
مطابقة بشرية + ذكاء اصطناعي
يجد خوارزمينا التطابقات، ويؤكد المنسق مدى الملاءمة
خياراتك جاهزة
قارن الأسعار، الباقات، والتواريخ. تحدث مع منسقك
تشعر بالحيرة لكثرة الخيارات؟
يوجه علاجك
منسقون شخصيون مدربون طبياً
| الترتيب. | طبيب | خبرة | مناسب لـ | ما الذي يميزهم عن غيرهم | العيادة والموقع | الاستشارة |
|---|---|---|---|---|---|---|
| #1 | 40سنة خبره ١٦ سنة | جراحة موس المجهرية | رائد في جراحة موس مع إجراء أكثر من 2000 عملية - معدلات شفاء أعلى من الاستئصال التقليدي. مدير قسم الأمراض الجلدية في مستشفيات إسبانية رائدة. | إسبانيا | من $350 | |
| #2 | 18سنة خبره ١٦ سنة | العلاج المناعي لسرطان الميلانوما | مساهم رئيسي في التجارب الخاصة بموافقات Pembrolizumab و Nivolumab - كان له دور فعال في تطورات العلاج المناعي. عضو في وحدة الميلانوما المرموقة في Vall d'Hebron. | إسبانيا | السعر عند الطلب |
Spanish oncology centers provide advanced melanoma surgeries like Mohs micrographic surgery and robot-assisted procedures. Specialists use sentinel lymph node biopsy for precise staging. These methods are available at JCI-accredited facilities in Barcelona and Madrid. Surgeons maintain high success rates using international oncology protocols.
Bookimed Expert Insight: Spain ranks 5th globally for medical tourism on Bookimed, largely driven by concentrated expertise in Barcelona. Dr. Joan Ramon Garces Gatnau at Centro Médico Teknon has performed over 2,000 Mohs surgeries. This high volume is rare, as many surgeons across Europe only offer standard wide excision. Choosing a high-volume specialist in Barcelona often ensures access to these refined, tissue-sparing techniques.
Patient Consensus: Patients note that seeking treatment in Madrid or Barcelona provides much faster access to specialized surgeons. They emphasize that private clinics significantly reduce wait times which is critical for early-stage staging.
International patients can access advanced immunotherapy and targeted therapy for melanoma at private Spanish hospitals. Centers like Centro Medico Teknon and Quironsalud Madrid offer checkpoint inhibitors and molecular diagnostics. Most facilities require proof of private insurance or out-of-pocket payments for non-resident access.
Bookimed Expert Insight: While many patients focus on drug availability, the real advantage in Spain is the volume of clinical research. Specialists like Dr. Jesus Soberino at Hospital Quiron Barcelona have directly led trials for major immunotherapies. This high level of academic involvement means private patients often receive protocols refined by the very doctors who helped approve them.
Patient Consensus: Patients emphasize the need to bring complete pathology records in English to avoid repeating expensive scans. Those treated in Madrid and Barcelona report much smoother communication due to better English-speaking staff at private oncology units.
Recovery after melanoma surgery in Spain typically takes 2 to 4 weeks for standard excisions. Initial wound healing occurs within 14 days. Full outcomes for incision lines and redness may take up to 1 year. Surgeons often remove stitches between 5 and 14 days post-operation.
Bookimed Expert Insight: Spain offers a unique advantage for melanoma patients through specialized units like the Baselga Institute at Hospital Quiron Barcelona. Data shows these centers integrate clinical trials directly into treatment plans. This means patients often access emerging immunotherapy protocols, like Pembrolizumab combinations, alongside standard surgical recovery. Choosing a JCI-accredited facility in Barcelona or Madrid ensures these advanced monitoring technologies are consolidated in one location.
Patient Consensus: Patients note that while the physical wound heals quickly, managing the monthly skin photo diary and regular surveillance visits is vital. Many emphasize that private clinics in Spain provide much faster scheduling for follow-up scans than the public system.
Spanish hospitals like Clinica Universidad de Navarra and Centro Médico Teknon hold prestigious Joint Commission International (JCI) accreditation for melanoma care. These facilities provide advanced surgical techniques. They also offer modern immunotherapy protocols. Leading centers often hold European Society for Medical Oncology certifications.
Bookimed Expert Insight: Spanish oncology centers show a strong trend of specialization. Clinica Universidad de Navarra maintains a 95% limb preservation rate. This is exceptional for complex melanoma cases. Choosing a center with high procedural volume is key. Centro Médico Teknon serves 10,000 patients annually. Highly active hospitals typically offer faster access to specialized Mohs micrographic surgery.
Patient Consensus: Patients note that finding a surgeon experienced in sentinel lymph node biopsy is vital. They often recommend private facilities to avoid wait times for suspicious lesions.
Non-resident patients can access clinical trials for melanoma drugs in Spain if they meet strict eligibility criteria. Major research centers in Madrid and Barcelona frequently enroll international participants for phase 1-3 trials. Patients must usually cover travel, diagnostics, and lodging expenses while study medications are provided at no cost.
Bookimed Expert Insight: Spanish oncology centers like Clinica Universidad de Navarra maintain exceptionally high international patient volumes, treating over 700,000 people from 70 countries. Our data shows that while trials offer the drug for free, pre-trial diagnostics in Spain can be significant. For instance, immunotherapy packages at top clinics like Teknon Medical Center start around $13,400 just for the medication and basic staging. Always confirm if the trial covers PET-CT and BRAF gene mutation testing, as these costs typically fall on the patient.
Patient Consensus: Patients note that non-EU residents often face bureaucractic hurdles with medical visas. Many recommend budgeting between $5,500 and $16,000 for initial workups and local advocacy to improve enrollment chances.
English-speaking melanoma patients in Spain access support through regional charities and specialized units in JCI-accredited hospitals. Organizations like MABS and Cancer Support Group Mallorca provide translation, transport, and counseling. Private centers like Centro Médico Teknon offer English-speaking coordinators and medical specialists to manage international cases.
Bookimed Expert Insight: Spain ranks 5th globally for medical requests, reflecting its status as a preferred hub for complex oncology. Our data shows hospitals like Hospital Quiron Barcelona and Clinica Universidad de Navarra handle high patient volumes, sometimes reaching 700,000 international cases annually. Selecting a center with historical JCI accreditation ensures that administrative support and medical safety meet rigorous international standards for non-Spanish speakers.
Patient Consensus: Patients note that while public hospitals have modern equipment, the language barrier makes private clinics or expat-led WhatsApp groups essential for emotional support. Many emphasize that a proactive approach is necessary because formal English-language support materials from local NGOs are often limited.